Skip to main content
. 2016 Feb 18;15:100. doi: 10.1186/s12936-016-1143-7

Fig. 1.

Fig. 1

Map indicating location of health facilities and associated catchment populations enrolled in the study, with allocation of IRS treatments per cluster and year [a LLINs + IRS (deltamethrin WG); b LLINs + IRS (EC pirimiphos methyl or lambdacyhalothrin CS); c LLINs + IRS (EC pirimiphos methyl or CS pirimiphos methyl or lambdacyhalothrin CS); and d LLINs + IRS (EC pirimiphos methyl or lambdacyhalothrin CS)]